Serina Therapeutics, Inc. (SER)
2.105
-0.14
(-6.44%)
USD |
NYAM |
Sep 21, 16:00
2.105
0.00 (0.00%)
After-Hours: 20:00
Serina Therapeutics Total Assets (Quarterly) : 25.81M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.81M |
| March 31, 2026 | 27.30M |
| December 31, 2025 | 7.122M |
| September 30, 2025 | 12.41M |
| June 30, 2025 | 8.941M |
| March 31, 2025 | 6.731M |
| September 30, 2024 | 7.435M |
| June 30, 2024 | 10.71M |
| March 31, 2024 | 10.86M |
| December 31, 2023 | 8.968M |
| September 30, 2023 | 12.21M |
| June 30, 2023 | 12.28M |
| March 31, 2023 | 12.53M |
| December 31, 2022 | 3.241M |
| September 30, 2022 | 2.008M |
| June 30, 2022 | 2.579M |
| March 31, 2022 | 2.716M |
| Date | Value |
|---|---|
| December 31, 2021 | 3.154M |
| September 30, 2021 | 2.427M |
| June 30, 2021 | 2.541M |
| March 31, 2021 | 3.16M |
| December 31, 2020 | 3.925M |
| September 30, 2020 | 4.203M |
| June 30, 2020 | 4.757M |
| March 31, 2020 | 5.092M |
| December 31, 2019 | 7.442M |
| September 30, 2019 | 8.183M |
| June 30, 2019 | 10.26M |
| March 31, 2019 | 12.32M |
| December 31, 2018 | 10.67M |
| September 30, 2018 | 12.14M |
| June 30, 2018 | 13.49M |
| March 31, 2018 | 10.63M |
| December 31, 2017 | 9.631M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.084M |
| Shareholders Equity (Quarterly) | 18.73M |
| Debt to Equity Ratio | 0.1713 |
| Current Ratio | 6.653 |
| Net Debt Paydown Yield | -1.14% |